Adrenoleukodystrophy
- 30 April 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 32 (5), 540
- https://doi.org/10.1212/wnl.32.5.540
Abstract
Varying combinations of central and peripheral nervous system disease and Addison disease were previously described in 14 members of a family. The diagnosis of adrenoleukodystrophy (ALD) was documented in affected individuals by increased content of C26:0fatty acid (hexacosanoic acid) in cultured skin fibroblasts. The abnormal C26/C.22 fatty acid ratios were not proportional to the neurologic syndrome, severity of disease, or duration.This publication has 10 references indexed in Scilit:
- AdrenoleukodystrophyNeurology, 1981
- Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells.Proceedings of the National Academy of Sciences, 1981
- The adrenoleukomyeloneuropathy complexNeurology, 1981
- Specificities of Human and Rat Brain Enzymes of Cholesterol Ester Metabolism Toward Very Long Chain Fatty Acids: Implication for Biochemical Pathogenesis of AdrenoleukodystrophyJournal of Neurochemistry, 1981
- Use of Adrenal Biopsy in Diagnosing AdrenoleukomyeloneuropathyArchives of Neurology, 1980
- Adrenoleukodystrophy: Evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous originBiochemical and Biophysical Research Communications, 1980
- High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patientsBiochemical and Biophysical Research Communications, 1978
- AdrenoleukodystrophyActa Neuropathologica, 1978
- AdrenomyeloneuropathyNeurology, 1977
- Qualitative alteration in substrate specificity of mitochondrial monoamine oxidase in brainJournal of Neurochemistry, 1976